Arcturus Therapeutics
ARCT • NASDAQ
Arcturus Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joseph E. Payne, with a market cap of $192.1M.
CEOJoseph E. Payne
Next Earnings
Upcoming earnings announcement for Arcturus Therapeutics
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.06
Revenue Estimate
$7.5M
Earnings History
Past 12 earnings reports for Arcturus Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Q4 2025 | -$1.03Est: -$0.82 | -25.6% | $7.2MEst: $14.3M | -49.8% |  10-K |
| Nov 10, 2025 | Q3 2025 | -$0.49Est: -$0.98 | +50.0% | $17.2MEst: $14.2M | +21.0% | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.34Est: -$0.96 | +64.6% | $28.3MEst: $20.6M | +37.4% | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.52Est: -$1.10 | +52.7% | $29.4MEst: $23.4M | +25.8% | 10-Q |
| Mar 6, 2025 | Q4 2024 | -$1.11Est: -$0.49 | -126.5% | $22.8MEst: $44.6M | -49.0% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.26Est: -$1.22 | +78.7% | $41.7MEst: $36.6M | +13.9% | 10-Q |
| Aug 5, 2024 | Q2 2024 | -$0.64Est: -$1.60 | +60.0% | $49.9MEst: $21.7M | +129.8% | 10-Q |
| May 8, 2024 | Q1 2024 | -$1.00Est: -$1.19 | +16.0% | $38.0MEst: $17.5M | +116.7% | 10-Q |
| Mar 7, 2024 | Q4 2023 | -$0.32Est: -$0.99 | +67.7% | $34.0MEst: $37.9M | -10.2% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.61Est: -$1.69 | +63.9% | $45.1MEst: $15.9M | +184.6% | — |
| Aug 7, 2023 | Q2 2023 | -$1.98Est: -$0.21 | -842.9% | $10.5MEst: $48.5M | -78.3% | 10-Q |
| May 9, 2023 | Q1 2023 | $0.62Est: $0.06 | +933.3% | $80.3MEst: $37.9M | +111.6% | — |